How to Reduce Performance Variation in Chronic HF Management

PROGRAM DESCRIPTION While outcomes have improved in other cardiovascular diseases, success has been limited in heart failure (HF) prevention and management, with significant variability in outcomes among national regions, gender, ...

PROGRAM DESCRIPTION
While outcomes have improved in other cardiovascular diseases, success has been limited in heart failure (HF) prevention and management, with significant variability in outcomes among national regions, gender, and communities of color. To address the 75% of chronic HF patients who do not receive optimal doses of guideline-recommended drugs, the American College of Cardiology and Haymarket Medical Education have joined forces to provide an expert faculty–guided, case-based approach to changing HF outcomes through optimal medical therapy. This webcast illustrates how clinicians can reduce performance variation and enhance outcomes in diverse populations through application of guideline-directed medical therapy strategies for chronic HF.

EDUCATIONAL OBJECTIVES
At the conclusion of this activity, participants should be better able to:Demonstrate appropriate selection of optimal medical therapy for heart failure patients, including African Americans, Hispanics, Native Americans, and women

---

Write the first review

Resource tags